143 related articles for article (PubMed ID: 8609887)
21. Site of action of the general anesthetic propofol in muscarinic M1 receptor-mediated signal transduction.
Murasaki O; Kaibara M; Nagase Y; Mitarai S; Doi Y; Sumikawa K; Taniyama K
J Pharmacol Exp Ther; 2003 Dec; 307(3):995-1000. PubMed ID: 14534362
[TBL] [Abstract][Full Text] [Related]
22. S111N mutation in the helical domain of human Gs(alpha) reduces its GDP/GTP exchange rate.
Brito M; Guzmán L; Romo X; Soto X; Hinrichs MV; Olate J
J Cell Biochem; 2002; 85(3):615-20. PubMed ID: 11968001
[TBL] [Abstract][Full Text] [Related]
23. NF546 [4,4'-(carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-alpha,alpha'-diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cells.
Meis S; Hamacher A; Hongwiset D; Marzian C; Wiese M; Eckstein N; Royer HD; Communi D; Boeynaems JM; Hausmann R; Schmalzing G; Kassack MU
J Pharmacol Exp Ther; 2010 Jan; 332(1):238-47. PubMed ID: 19815812
[TBL] [Abstract][Full Text] [Related]
24. G-protein coupled activation of potassium channels by endogenous neuropeptides in snail neurons.
Kiss T
Eur J Neurosci; 2005 Apr; 21(8):2177-85. PubMed ID: 15869514
[TBL] [Abstract][Full Text] [Related]
25. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
Odagaki Y; Toyoshima R
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1304-12. PubMed ID: 16824659
[TBL] [Abstract][Full Text] [Related]
26. Adrenergic stimulation of lacrimal protein secretion is mediated by G(q/11)alpha and G(s)alpha.
Meneray MA; Fields TY
Curr Eye Res; 2000 Aug; 21(2):602-7. PubMed ID: 11148596
[TBL] [Abstract][Full Text] [Related]
27. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
Newman-Tancredi A; Cussac D; Audinot V; Pasteau V; Gavaudan S; Millan MJ
Mol Pharmacol; 1999 Mar; 55(3):564-74. PubMed ID: 10051542
[TBL] [Abstract][Full Text] [Related]
28. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
Wang HY; Friedman E; Olmstead MC; Burns LH
Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
[TBL] [Abstract][Full Text] [Related]
29. Identification and properties of a Gs protein in catfish liver membranes.
Fabbri E; Selva C; Piano A; Caselli F; Capuzzo A
Gen Comp Endocrinol; 2002 Feb; 125(3):340-8. PubMed ID: 11884079
[TBL] [Abstract][Full Text] [Related]
30. A 50 KDa protein modulates guanine nucleotide binding of transglutaminase II.
Baek KJ; Das T; Gray CD; Desai S; Hwang KC; Gacchui R; Ludwig M; Im MJ
Biochemistry; 1996 Feb; 35(8):2651-7. PubMed ID: 8611570
[TBL] [Abstract][Full Text] [Related]
31. Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle.
Murthy KS; Makhlouf GM
Mol Pharmacol; 1996 Oct; 50(4):870-7. PubMed ID: 8863832
[TBL] [Abstract][Full Text] [Related]
32. G alpha(i) and G alpha(o) are target proteins of reactive oxygen species.
Nishida M; Maruyama Y; Tanaka R; Kontani K; Nagao T; Kurose H
Nature; 2000 Nov; 408(6811):492-5. PubMed ID: 11100733
[TBL] [Abstract][Full Text] [Related]
33. Levels of Gsα(short and long), Gα(olf) and Gβ(common) subunits, and calcium-sensitive adenylyl cyclase isoforms (1, 5/6, 8) in post-mortem human brain caudate and cortical membranes: comparison with rat brain membranes and potential stoichiometric relationships.
Zalduegui A; López de Jesús M; Callado LF; Meana JJ; Sallés J
Neurochem Int; 2011 Feb; 58(2):180-9. PubMed ID: 21115086
[TBL] [Abstract][Full Text] [Related]
34. Antagonistic properties of the suramin analogue NF023 at heterologously expressed P2X receptors.
Soto F; Lambrecht G; Nickel P; Stühmer W; Busch AE
Neuropharmacology; 1999 Jan; 38(1):141-9. PubMed ID: 10193905
[TBL] [Abstract][Full Text] [Related]
35. Interaction of the D2short dopamine receptor with G proteins: analysis of receptor/G protein selectivity.
Nickolls SA; Strange PG
Biochem Pharmacol; 2003 Apr; 65(7):1139-50. PubMed ID: 12663049
[TBL] [Abstract][Full Text] [Related]
36. Molecular determinants of potent P2X2 antagonism identified by functional analysis, mutagenesis, and homology docking.
Wolf C; Rosefort C; Fallah G; Kassack MU; Hamacher A; Bodnar M; Wang H; Illes P; Kless A; Bahrenberg G; Schmalzing G; Hausmann R
Mol Pharmacol; 2011 Apr; 79(4):649-61. PubMed ID: 21191044
[TBL] [Abstract][Full Text] [Related]
37. Molecular modeling of G-protein coupled receptor kinase 2: docking and biochemical evaluation of inhibitors.
Kassack MU; Högger P; Gschwend DA; Kameyama K; Haga T; Graul RC; Sadée W
AAPS PharmSci; 2000; 2(1):E2. PubMed ID: 11741218
[TBL] [Abstract][Full Text] [Related]
38. Development of Gs-selective inhibitory compounds.
Nanoff C; Kudlacek O; Freissmuth M
Methods Enzymol; 2002; 344():469-80. PubMed ID: 11771404
[No Abstract] [Full Text] [Related]
39. Mutagenesis of the conserved residue Glu259 of Gsalpha demonstrates the importance of interactions between switches 2 and 3 for activation.
Warner DR; Romanowski R; Yu S; Weinstein LS
J Biol Chem; 1999 Feb; 274(8):4977-84. PubMed ID: 9988742
[TBL] [Abstract][Full Text] [Related]
40. Antiproliferative and angiostatic activity of suramin analogues.
Firsching A; Nickel P; Mora P; Allolio B
Cancer Res; 1995 Nov; 55(21):4957-61. PubMed ID: 7585536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
